| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |